Cloning vectors and techniques for exonuclease-hybridization restriction mapping.
Tartof
K D
KD
Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111.
D001483:Base Sequence; D003001:Cloning, Molecular / Q000379:methods*; D003360:Cosmids; D004274:DNA, Recombinant / Q000096:biosynthesis* / Q000302:isolation & purification; D015252:Deoxyribonucleases, Type II Site-Specific / Q000378:metabolism*; D004587:Electrophoresis, Agar Gel / Q000379:methods; D004926:Escherichia coli / Q000235:genetics*; D005090:Exodeoxyribonucleases / Q000378:metabolism*; D005822:Genetic Vectors; D007202:Indicators and Reagents; D008969:Molecular Sequence Data; D009693:Nucleic Acid Hybridization; D009838:Oligodeoxyribonucleotides; D010957:Plasmids; D015183:Restriction Mapping; D013379:Substrate Specificity
D004274:DNA, Recombinant; D007202:Indicators and Reagents; D009838:Oligodeoxyribonucleotides; D005090:Exodeoxyribonucleases; C020133:exodeoxyribonuclease III; D015252:Deoxyribonucleases, Type II Site-Specific; C038565:GCGGCCGC-specific type II deoxyribonucleases